2nd ProCAncer-I Project Dissemination Event in Lisbon

An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum: In Europe, prostate cancer (PC) is the second most frequent type of cancer in men and the third most lethal. Current clinical practices lead to overdiagnosis and overtreatment, necessitating more effective tools for discriminating between aggressive and non-aggressive disease. The EU-funded ProCAncer-I project proposes to develop advanced artificial intelligence models to address unmet clinical needs: diagnosis, metastases detection and prediction of response to treatment. To achieve this, partners will generate a large interoperable repository of health images, and a scalable high-performance computing platform hosting the largest collection of PC Magnetic Resonance Images used for developing robust PC AI models. To ensure the rapid clinical implementation of the models developed, the project’s partners will robustly monitor performance, accuracy and reproducibility. 

Welcome by Coordinating Team

We are very glad to lead a very ambitious and health-driven project that could end to alleviating and helping thousands of men to tackle prostate cancer in a more personalized way supporting a better quality of life

The Coordinating Team

Manolis Tsiknakis

Prof. Manolis Tsiknakis
(Coordinator)

Dr. Nikolaos Papanikolaou
(Scientific Manager)

Prof. Kostas Marias
(Technical Manager)

Prof. Daniele Regge
(Clinical Manager)

The ProCAncer-I project is one of the founding projects of the FUTURE-AI.

FUTURE-AI is an international, multi-stakeholder initiative for defining and maintaining concrete guidelines that will facilitate the design, development, validation, and deployment of trustworthy AI solutions in medical imaging based on six guiding principles: Fairness, Universality, Traceability, Usability, Robustness, and Explainability.

Project Information

Months (Duration)

Euros (Total Budget )

Grant Agreement Nr.

Funded

This project has received funding from the European Union’s Horizon 2020 research and innovation programme

|

Topic

DT-TDS-05-2020:
AI for Health Imaging

Highlights

The ProCAncer-I at the IEEE Engineering in Medicine & Biology Society (EMBS) in Malta

The ProCAncer-I at the IEEE Engineering in Medicine & Biology Society (EMBS) in Malta

The ProCAncer-I Consortium is organising a mini symposium under the scope Data Engineering in Cancer, chaired by prof. Dimitris Fotiadis and are inviting every interested stakeholder to participate. The mini symposium will take place during the IEEE EMBS International Conference on Data Science and Engineering in Healthcare, Medicine & Biology, in Malta (Hilton Malta Hotel) on December 7, 2023 – December 9, 2023, on the second day.

Prof Tsiknakis: Launch of the federal European infrastructure for cancer imaging

Prof Tsiknakis: Launch of the federal European infrastructure for cancer imaging

The EUCAIM (European Federation for Cancer Images) project is the cornerstone of the European Cancer Imaging Initiative, launched by the European Commission, within the framework of the European Beating Cancer Plan, emphasized Prof. Manolis Tsiknakis, as Coordinator of the ProCAncer-I project and Affiliated Professor at the Computational Biomedicine Laboratory (CBML), speaking at the Health IT conference.

Twitter feed is not available at the moment.

Stay in touch!